Cardiology Research Institute, Tomsk National Research Medical Center
Aim. To test the hypothesis that the combined use of ivabradine (If inhibitor) and ranolazine (late sodium channel blocker) can reduce the ventricular rate in patients with permanent atrial fibrillation (AF) resistant to standard heart rate-lowering therapy.Material and methods. The study included 2...
Saved in:
Main Authors: | B. A. Tatarsky, N. V. Kazennova, R. E. Batalov, S. V. Popov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«FIRMA «SILICEA» LLC
2020-08-01
|
Series: | Российский кардиологический журнал |
Subjects: | |
Online Access: | https://russjcardiol.elpub.ru/jour/article/view/3388 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IVABRADINE OUTSIDE THE CLINICAL GUIDELINES: INTEREST OF A PRACTITIONER
by: E. I. Tarlovskaya
Published: (2018-04-01) -
CORRELATION OF THE ACHIEVED VENTRICULAR CONTRACTION RATE CONTROL LEVEL WITH LIFE QUALITY IN ELDERLY PATIENTS WITH PERMANENT ATRIAL FIBRILLATION
by: S. G. Кanorskiy, et al.
Published: (2018-05-01) -
Comparative efficacy of amiodarone with ivabradin combination or amiodarone with bisoprolol combination in the prevention of atrial fibrillation recurrence in pa- tients with left ventricular diastolic dysfunction
by: K. G. Adamyan, et al.
Published: (2015-11-01) -
Cardiology Research Institute, Tomsk National Research Medical Center
by: E. V. Grakova, et al.
Published: (2022-08-01) -
ATRIAL FIBRILLATION AND HEART FAILURE: APPROACHES TO ANTITHROMBOTIC THERAPY
by: B. A. Tatarsky, et al.
Published: (2017-08-01)